The effect of distal pulmonary obstruction or elevated atrial pressures on pulmonary flow and pulmonary vascular disease: a mathematical flow circuit analogy model-based analysis
- 8 Downloads
Late presentation of large left to right shunts is a major problem in developing countries and evaluating the operability is a challenge during preoperative evaluation. The factors that determine the development and progression of the pulmonary vascular disease are still largely unknown, though there is evidence to show that increased pulmonary flow is the main contributing factor. We have found cases of operability despite late presentation of ventricular septal defect (VSD). In some of these cases, the reason for operability may lie in associations. We herein attempt to provide a mathematical explanation for their operability.
Aims and objectives
To assess the effect of different levels of obstruction and elevated ventricular end-diastolic pressure on pulmonary flow.
Materials and methods
Mathematical flow analogy models were constructed and analysed based on Ohm’s law and the laws governing flow in series and parallel flow circuits.
Any narrowing in the pulmonary circulation produces a reduction in pulmonary blood flow and the pulmonary to systemic blood flow ratio, irrespective of its position. This increases the systemic flow and blood pressure if the ventricular performance remains constant. A rise in ventricular end-diastolic pressure reduces the total cardiac output, pulmonary flow and systemic blood flow with a preserved pulmonary to systemic flow ratio. The absolute reduction in pulmonary flow will exceed the absolute reduction in systemic flow, with its ratio being in proportion to the ratio of systemic to pulmonary vascular resistance. However, a higher pressure will be transmitted distally in these settings. These mechanisms of flow reduction may prevent irreversible pulmonary vascular disease.
Distal pulmonary obstruction or elevated ventricular end-diastolic pressure can reduce pulmonary blood flow and may prevent irreversible pulmonary vascular disease. Clinical studies in this direction are recommended for validation.
KeywordsPulmonary vascular disease Left to right shunts Ventricular septal defect
The authors thank Shelly Leonardy, graphic designer from University of Melbourne, for the illustrations.
Compliance with ethical standards
Conflict of interest
- 1.D'Alto M, Mahadevan VS. Pulmonary arterial hypertension associated with congenital heart disease. Eur Respir Rev. 2012;21:328–37.Google Scholar
- 2.Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation. 2007;115:1039–150.Google Scholar
- 3.Krishna Kumar R, Viswanathan S. Hemodynamic assessment of congenital heart defects with left to right shunts and pulmonary hypertension. JICC. 2011;1:28–35.Google Scholar
- 4.Corone P, Doyon F, Gaudeau S, et al. Natural history of ventricular septal defect. A study involving 790 cases. Circulation. 1977;55:908–15.Google Scholar
- 5.Dinh Xuan AT, Higenbottam TW, Clelland C, Pepke-Zaba J, Cremona G, Wallwork J. Impairment of pulmonary endothelium- dependent relaxation in patients with Eisenmenger’s syndrome. Br J Pharmacol.1990;99:9–10.Google Scholar
- 6.Celermajer DS, Cullen S, Deanfield JE. Impairment of endothelium- dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation 1993;87:440–6.Google Scholar
- 7.Lam C, Peterson TE, Croatt AJ, Nath KA, Katusic ZS. Functional adaptation and remodelling of pulmonary artery in flow-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol.2005;289:H2334–H41.Google Scholar
- 8.Hollman A, Hamed M. Mitral valve disease with ventricular septal defect. Br Heart J. 1965;27:274–85.Google Scholar
- 9.Hisatomi K, Isomura T, Sato T, Kosuga K, Ohishi K, Katoh H. Mitral valve repair for mitral regurgitation with ventricular septal defect in children. Ann Thorac Surg. 1996;62:1773–7.Google Scholar
- 10.Agarwal S, Airan B, Chowdhury UK, et al. Ventricular septal defect with congenital mitral valve disease:long-term results of corrective surgery. Indian Heart J. 2002;54:67–73.Google Scholar
- 11.Guyton A, Hall J. Chapter 14: Overview of the Circulation; Medical Physics of Pressure, Flow, and Resistance". In:Gruliow R, editor. Textbook of Medical Physiology. 11th Edition, Philadelphia: Elsevier Inc; 2006. p.164.Google Scholar
- 12.Bird J. Electrical and Electronic Principles and Technology. Routledge.2010: 63–76.Google Scholar
- 13.Rabinovitch M, Keane JF, Norwood WI, Castaneda AR, Reid L. Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects. Circulation. 1984;69:655–67.Google Scholar
- 14.Roman KS, Kellenberger CJ, Macgowan CK, et al. How is pulmonary arterial blood flow affected by pulmonary venous obstruction in children? A phase-contrast magnetic resonance study. Pediatr Radiol. 2005;35:580–6.Google Scholar
- 15.Rabinovitch M, Haworth SG, Castaneda AR, Nadas AS, Reid LM. Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. Circulation. 1978;58:1107–22.Google Scholar
- 16.Burri PH. Structural aspects of postnatal lung development - alveolar formation and growth. Biol Neonate. 2006;89:313–22.Google Scholar
- 17.Haworth SG, Reid L. Quantitative structural study of pulmonary circulation in the newborn with aortic atresia, stenosis, or coarctation. Thorax. 1977;32:121–8.Google Scholar
- 18.Tandon HD, Kasturi J. Pulmonary vascular changes associated with isolated mitral stenosis in India. Br Heart J. 1975;37:26–36.Google Scholar
- 19.Kaul TK, Bain WH, Jones JV, et al. Mitral valve replacement in the presence of severe pulmonary hypertension. Thorax. 1976;31:332–6.Google Scholar
- 20.Myers PO, Tissot C, Beghetti M . Assessment of operability of patients with pulmonary arterial hypertension associated with congenital heart disease. Circ J. 2014;78:4–11.Google Scholar
- 21.Kozlik-Feldmann R, Hansmann G, Bonnet D Schranz D, Apitz C, Michel-Behnke I. Pulmonary hypertension in children with congenital heart disease (PAH-CHD, PPHVD-CHD). Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart. 2016;102:ii42–ii48.Google Scholar